Top Highlights for July 2014: (Please click on read more to see details)
- India’s drug major Lupin announces two new R&D centres in the US
- India based Cipla to expand its global footprint by investing $168 million in its UK subsidiary Read more
- Glenmark Pharma, India to build a state-of-the-art $100 million manufacturing facility in US
- India based Strides Arcolab acquires majority stake in Bafna Pharma for cash consideration of $8 million
- Sun Pharma, India acquires U.S.-based Pharmalucence Read more
- Cipla and BioQuiddity, US announce EU commercial partnership for a pain management product Read more
- Serum Institute of India acquires worldwide exclusive rights from NeuClone, Australia for marketing and sales of biosimilar drugs
- Strides Arcolab of India invests in US based Oncobiologics to access expertise in bio-pharma and next generation bio-therapeutics Read more
- Lupin of India may bid For acquiring GSK's Mature Drugs
For more such news and updates on Global Life Science Business in India please join our Group on LinkedIn by the same name.